Actively Recruiting
A Registered Observational Cohort Study of Charcot-Marie-Tooth Disease
Led by Ning Wang, MD., PhD. ยท Updated on 2022-01-11
500
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to analyze natural history data from patients with Charcot-Marie-Tooth disease and related disorders in China. It focuses on assessing clinical, genetic, and epigenetic features to better understand the condition and improve clinical management. The study is observational and gathers detailed information to support patient care optimization. Participants include patients clinically or genetically diagnosed with Charcot-Marie-Tooth disease and unrelated healthy controls. The study collects data over time to observe disease progression and characteristics without administering any treatments or interventions. Throughout the study, researchers will monitor changes in the Charcot-Marie-Tooth Neuropathy Score (CMTNS) over up to six months. Participants will undergo assessments that help track the disease's impact and progression. The study is open to all genders and ages, with voluntary participation and long-term observation planned until the study end date in 2049.
CONDITIONS
Brief Title
A Registered Cohort Study on Charcot-Marie-Tooth Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with the clinical diagnosis of Charcot-Marie-Tooth disease
- Genetic diagnosis of patients with Charcot-Marie-Tooth disease
- Unrelated healthy controls
You will not qualify if you...
- Decline to participate
- Other peripheral neuropathy caused by trauma, immunity and toxicosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 months
Participants are observed to track changes in Charcot-Marie-Tooth Neuropathy Score over time.
Visits occur during the monitoring period to assess neuropathy scores
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Fujian Medical University
Fuzhou, China
Actively Recruiting
Research Team
N
Ning Wang, MD, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here